Clinical Trial Update: A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on relapse prevention with levomilnacipran ER in adults with major depressive disorder; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder
• Major Depressive Disorder

Drugs mentioned

• levomilnacipran extended release (levomilnacipran)

Snippet

Sponsor: Forest Laboratories | Conditions: Depressive Disorder, Major | Phase 4 | Status: COMPLETED | Results posted: 2018-10-29